The Centers for Disease Control and Prevention recently posted updated considerations for ending isolation for adults with COVID-19, based on new evidence.

CDC said the guidance does not apply to severely immunocompromised individuals; rather, it is intended to limit unnecessary extended isolation and preserve laboratory testing resources.

Under the guidance, isolation for most people with COVID-19 can be discontinued 10 days after symptom onset, provided there are improvements of symptoms and no fever for 24 hours without the use of fever-reducing medications.

Related News Articles

Blog
The RAND Corporation recently released the fifth iteration of its biannual hospital price report. The AHA has previously highlighted significant flaws with…
Headline
Adults age 65 and older are encouraged to receive an updated dosage of the COVID-19 vaccine, the Centers for Disease Control and Prevention announced April 25…
Headline
The Pfizer and Moderna COVID-19 vaccines can cause myocarditis, but do not appear to cause infertility, Guillain-Barré syndrome, Bell’s palsy, thrombosis with…
Headline
The Food and Drug Administration recently granted emergency use authorization for the first over-the-counter home antigen test to detect both flu and COVID-19…
Headline
Centers for Disease Control and Prevention Director Mandy Cohen, M.D., Feb. 28 endorsed a recommendation by its Advisory Committee on Immunization Practices…
Headline
Paxlovid may no longer be distributed with an emergency use label after March 8, the Food and Drug Administration announced. Providers may dispense unexpired…